Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
401k Retirement Calculator
Mortgage Calculator
Popular
Compound Interest Calculator
Dollar Cost Averaging
New
Student Loan Calculator
Auto Loan Calculator
Personal Finance
News
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
TipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
CNTX
Stock Latest News
Company Announcements
Context Therapeutics Advances Cancer Trial with FDA Submission
29d ago
8K
CNTX
Premium
Press Releases
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
29d ago
CNTX
Premium
The Fly
Context Therapeutics submits IND application for CTIM-76
29d ago
CNTX
Premium
Press Releases
Context Therapeutics Reports Full Year 2023 Operating and Financial Results
1M ago
CNTX
Premium
The Fly
Context Therapeutics expects cash to fund operations into late 2024
1M ago
CNTX
Premium
The Fly
Context Therapeutics reports 2023 EPS ($1.50) vs. (93c) last year
1M ago
CNTX
Premium
Pre-Earnings
Context Therapeutics, Inc. (CNTX) Q4 Earnings Cheat Sheet
1M ago
CNTX
Premium
Company Announcements
Context Therapeutics Unveils Updated Corporate Strategy Presentation
2M ago
8K
CNTX
Premium
Press Releases
Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results
6M ago
CNTX
Premium
The Fly
Context Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
6M ago
CNTX
Premium
The Fly
Context Therapeutics announces preclinical data on CTIM-76
6M ago
CNTX
Premium
Press Releases
Context Therapeutics Announces Acceptance of Abstract to be Presented at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
7M ago
CNTX
Premium
The Fly
Context Therapeutics initiated with a Buy at Maxim
8M ago
CNTX
Premium
Press Releases
Context Therapeutics Reports Second Quarter 2023 Operating and Financial Results
9M ago
CNTX
Premium
Press Releases
Context Therapeutics to Participate in Two August 2023 Investor Conferences
9M ago
CNTX
Premium
Press Releases
Context Therapeutics Reports First Quarter 2023 Operating and Financial Results
12M ago
CNTX
Premium
Press Releases
Context Therapeutics to Participate in Two April 2023 Investor Conferences
1y ago
CNTX
Premium
The Fly
Context Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1y ago
CNTX
Premium
Press Releases
Context Therapeutics Reports Full Year 2022 Financial Results and Recent Pipeline Updates
1y ago
CNTX
Premium
Press Releases
Context Therapeutics Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2023
1y ago
CNTX
Premium
Press Releases
Context Therapeutics Highlights Clinical Responses from the Phase 2 OATH Clinical Trial Evaluating ONA-XR for the Treatment of Endometrial Cancer
1y ago
CNTX
Premium
The Fly
Context Therapeutics highlights clinical responses from Phase 2 OATH trial
1y ago
CNTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
